Clinical Significance of Subclassification of Papillary Renal Cell Carcinoma: Comparison of Clinicopathologic Parameters and Oncologic Outcomes Between Papillary Histologic Subtypes 1 and 2 Using the Korean Renal Cell Carcinoma Database
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ha, Y.-S. | - |
dc.contributor.author | Chung, J.-W. | - |
dc.contributor.author | Choi, S.H. | - |
dc.contributor.author | Lee, J.N. | - |
dc.contributor.author | Kim, H.T. | - |
dc.contributor.author | Kim, T.-H. | - |
dc.contributor.author | Chung, S.K. | - |
dc.contributor.author | Byun, S.-S. | - |
dc.contributor.author | Hwang, E.C. | - |
dc.contributor.author | Kang, S.H. | - |
dc.contributor.author | Hong, S.-H. | - |
dc.contributor.author | Chung, J. | - |
dc.contributor.author | Kwak, C. | - |
dc.contributor.author | Kim, Y.-J. | - |
dc.contributor.author | Kwon, T.G. | - |
dc.contributor.author | Korean Renal Cell Carcinoma Study Group | - |
dc.date.accessioned | 2021-12-20T00:33:26Z | - |
dc.date.available | 2021-12-20T00:33:26Z | - |
dc.date.created | 2021-08-31 | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 1558-7673 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/132222 | - |
dc.description.abstract | The aim of the present study was to investigate the clinical significance of the subclassification of papillary renal cell carcinoma (pRCC) in a multi-institutional study of 274 Korean patients with pRCC. Type 2 pRCC displayed more aggressive clinicopathologic characteristics; however, no significant differences in prognosis were found between types 1 and 2 pRCC. Among patients with pRCC, the pathologic T stage was the only prognosticator. Introduction The aims of the present study were to compare the clinicopathologic characteristics between type 1 and type 2 papillary renal cell carcinoma (pRCC) and to evaluate the effect of the subclassification of pRCC on the oncologic outcomes after surgery. Materials and Methods The records of 274 patients with pRCC in the Korean renal cell carcinoma (KORCC) database were included for evaluation. Of the 274 patients, 118 had type 1 pRCC and 156 had type 2 pRCC. The patient characteristics, including clinicopathologic parameters, were investigated, and the oncologic outcomes were evaluated. Results The mean patient age was significantly older in the type 2 pRCC group. Compared with type 1 pRCC tumors, type 2 pRCC tumors were more often localized to the renal hilum (P = .030). Patients with type 2 pRCC had a greater incidence of Fuhrman grade 3 and 4 tumors than those with type 1 pRCC (78.8% vs. 22.8; P < .001). Tumor necrosis and capsular invasion were more frequently found in type 2 pRCC (P = .008 and P = .007, respectively). At a mean follow-up period of 38.0 months (interquartile range, 11.8-57.3 months), the subclassification of pRCC did not influence the prognosis of patients with pRCC. Conclusion From the information available in the KORCC database, we identified significant differences in clinicopathologic variables, including age, Fuhrman grade, tumor location, tumor necrosis, and capsular invasion between type 1 and 2 pRCC. Although type 2 pRCC had more aggressive clinicopathologic characteristics, subclassification of pRCC did not affect the oncologic outcomes. © 2016 Elsevier Inc. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Elsevier Inc. | - |
dc.subject | antineoplastic agent | - |
dc.subject | adult | - |
dc.subject | Article | - |
dc.subject | body mass | - |
dc.subject | cancer immunotherapy | - |
dc.subject | cancer localization | - |
dc.subject | cancer patient | - |
dc.subject | cancer prognosis | - |
dc.subject | cancer radiotherapy | - |
dc.subject | cancer specific survival | - |
dc.subject | cancer staging | - |
dc.subject | cancer surgery | - |
dc.subject | comparative study | - |
dc.subject | controlled study | - |
dc.subject | female | - |
dc.subject | follow up | - |
dc.subject | hand assisted laparoscopy | - |
dc.subject | histology | - |
dc.subject | human | - |
dc.subject | kidney carcinoma | - |
dc.subject | major clinical study | - |
dc.subject | male | - |
dc.subject | middle aged | - |
dc.subject | oncological parameters | - |
dc.subject | outcome assessment | - |
dc.subject | overall survival | - |
dc.subject | radical nephrectomy | - |
dc.subject | recurrence free survival | - |
dc.subject | tumor volume | - |
dc.subject | type 1 papillary renal cell carcinoma | - |
dc.subject | type 2 papillary renal cell carcinoma | - |
dc.subject | aged | - |
dc.subject | cancer grading | - |
dc.subject | classification | - |
dc.subject | disease free survival | - |
dc.subject | factual database | - |
dc.subject | Kaplan Meier method | - |
dc.subject | kidney tumor | - |
dc.subject | prognosis | - |
dc.subject | renal cell carcinoma | - |
dc.subject | South Korea | - |
dc.subject | Adult | - |
dc.subject | Aged | - |
dc.subject | Carcinoma, Renal Cell | - |
dc.subject | Databases, Factual | - |
dc.subject | Disease-Free Survival | - |
dc.subject | Female | - |
dc.subject | Humans | - |
dc.subject | Kaplan-Meier Estimate | - |
dc.subject | Kidney Neoplasms | - |
dc.subject | Male | - |
dc.subject | Middle Aged | - |
dc.subject | Neoplasm Grading | - |
dc.subject | Prognosis | - |
dc.subject | Republic of Korea | - |
dc.title | Clinical Significance of Subclassification of Papillary Renal Cell Carcinoma: Comparison of Clinicopathologic Parameters and Oncologic Outcomes Between Papillary Histologic Subtypes 1 and 2 Using the Korean Renal Cell Carcinoma Database | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kang, S.H. | - |
dc.identifier.doi | 10.1016/j.clgc.2016.07.020 | - |
dc.identifier.scopusid | 2-s2.0-84994137658 | - |
dc.identifier.bibliographicCitation | Clinical Genitourinary Cancer, v.15, no.2, pp.e181 - e186 | - |
dc.relation.isPartOf | Clinical Genitourinary Cancer | - |
dc.citation.title | Clinical Genitourinary Cancer | - |
dc.citation.volume | 15 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | e181 | - |
dc.citation.endPage | e186 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | antineoplastic agent | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | body mass | - |
dc.subject.keywordPlus | cancer immunotherapy | - |
dc.subject.keywordPlus | cancer localization | - |
dc.subject.keywordPlus | cancer patient | - |
dc.subject.keywordPlus | cancer prognosis | - |
dc.subject.keywordPlus | cancer radiotherapy | - |
dc.subject.keywordPlus | cancer specific survival | - |
dc.subject.keywordPlus | cancer staging | - |
dc.subject.keywordPlus | cancer surgery | - |
dc.subject.keywordPlus | comparative study | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | hand assisted laparoscopy | - |
dc.subject.keywordPlus | histology | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | kidney carcinoma | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | oncological parameters | - |
dc.subject.keywordPlus | outcome assessment | - |
dc.subject.keywordPlus | overall survival | - |
dc.subject.keywordPlus | radical nephrectomy | - |
dc.subject.keywordPlus | recurrence free survival | - |
dc.subject.keywordPlus | tumor volume | - |
dc.subject.keywordPlus | type 1 papillary renal cell carcinoma | - |
dc.subject.keywordPlus | type 2 papillary renal cell carcinoma | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | cancer grading | - |
dc.subject.keywordPlus | classification | - |
dc.subject.keywordPlus | disease free survival | - |
dc.subject.keywordPlus | factual database | - |
dc.subject.keywordPlus | Kaplan Meier method | - |
dc.subject.keywordPlus | kidney tumor | - |
dc.subject.keywordPlus | prognosis | - |
dc.subject.keywordPlus | renal cell carcinoma | - |
dc.subject.keywordPlus | South Korea | - |
dc.subject.keywordPlus | Adult | - |
dc.subject.keywordPlus | Aged | - |
dc.subject.keywordPlus | Carcinoma, Renal Cell | - |
dc.subject.keywordPlus | Databases, Factual | - |
dc.subject.keywordPlus | Disease-Free Survival | - |
dc.subject.keywordPlus | Female | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Kaplan-Meier Estimate | - |
dc.subject.keywordPlus | Kidney Neoplasms | - |
dc.subject.keywordPlus | Male | - |
dc.subject.keywordPlus | Middle Aged | - |
dc.subject.keywordPlus | Neoplasm Grading | - |
dc.subject.keywordPlus | Prognosis | - |
dc.subject.keywordPlus | Republic of Korea | - |
dc.subject.keywordAuthor | KORCC database | - |
dc.subject.keywordAuthor | Nephrectomy | - |
dc.subject.keywordAuthor | pRCC | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | T stage | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.